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Abstract
Background: Caffeine is the most commonly consumed psycho-stimulant in the world. The
effects of caffeine on the body have been extensively studied; however, its effect on the structure
of the brain has not been investigated to date.
Results: In the present study we found that the long-term consumption of caffeine can induce
ventriculomegaly; this was observed in 40% of the study rats. In the caffeine-treated rats with
ventriculomegaly, there was increased production of CSF, associated with the increased expression
of Na+, K+-ATPase and increased cerebral blood flow (CBF). In contrast to the chronic effects,
acute treatment with caffeine decreased the production of CSF, suggesting 'effect inversion'
associated with caffeine, which was mediated by increased expression of the A1 adenosine
receptor, in the choroid plexus of rats chronically treated with caffeine. The involvement of the A1
adenosine receptor in the effect inversion of caffeine was further supported by the induction of
ventriculomegaly and Na+, K+-ATPase, in A1 agonist-treated rats.
Conclusion: The results of this study show that long-term consumption of caffeine can induce
ventriculomegaly, which is mediated in part by increased production of CSF. Moreover, we also
showed that adenosine receptor signaling can regulate the production of CSF by controlling the
expression of Na+, K+-ATPase and CBF.
Background
Methylxanthine caffeine is present in many common bev-
erages, and is widely consumed worldwide [1,4]. Caffeine
consumption has been estimated to be 76 mg per person
per day worldwide, as high as 238 mg per person per day
in the United States and Canada, and more than 400 mg
per person per day in Sweden and Finland [5,6]. Caffeine
is absorbed rapidly after oral administration and distrib-
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uted to various organs and tissues. In the liver, caffeine is
metabolized to dimethyl- and monomethylxanthines,
dimethyl and monomethyl uric acids, trimethyl- and
dimethylallantoin, and uracil derivatives. Some metabo-
lites of caffeine including 1,3-dimethylxanthine (theo-
phylline) and 1,7-dimethylxanthine (paraxanthine) have
pharmacological activity similar to caffeine [4]. The half-
life of caffeine is ~5 hours in humans and ~1 hour in rats
[4,7].
The main mechanism of action of caffeine is by antago-
nism of the adenosine receptors [4]. Among four adenos-
ine receptors (A1, A2A, A2B, A3), the A1 and A2A receptors
are high affinity receptors and are abundantly expressed.
These receptors can be activated at low basal adenosine
concentrations. Thus, by blocking the action of endog-
enous ligands, at these receptors, caffeine can exert its bio-
logical effects. A2B  and A3 adenosine receptors require
higher concentrations of adenosine for activation. Adeno-
sine A1  receptors have been associated with caffeine's
effect on neurotransmitter release. A2A receptor knockout
mice respond less or not at all to caffeine on locomotion
and wakefulness testing [8,10].
Interestingly, short- and long-term treatment with caffeine
has different effects. Short-term treatment with caffeine
decreases the threshold for convulsions [11,12]. By con-
trast, long-term treatment with caffeine increases the
threshold for convulsions [13,14]. Moreover, short-term
treatment with caffeine worsens ischemia-induced dam-
age [15], whereas, long-term treatment with caffeine
reduces such damage [16,17]. Despite these different
effects of long-term and short-term treatment, the under-
lying mechanism associated with the long-term effects of
caffeine has not been well characterized.
While studying the underlying mechanisms of caffeine-
induced impairment in learning and memory, we noted
frequent enlargement of the ventricles in caffeine-treated
rats. Therefore, this study was undertaken to investigate
the underlying mechanisms of caffeine-induced ventricu-
lomegaly. We found that overproduction of CSF in caf-
feine-treated rats causes ventriculomegaly.
Methods
Animals
Male Sprague-Dawley rats (body weight 280 - 320 g, 7-10
weeks old) were caged in an air-conditioned room main-
tained at 22 ± 2°C, relative humidity 50 ± 10%, with a 12/
12 h light/dark cycle. Animals had free access to tap water
and were fed a conventional rat chow diet. They were
acclimated for 1 week prior to beginning the study. Proce-
dures related to animal care were in accord with the guide-
lines of the 'Guide for the Care and Use of Laboratory
Animals' [18]. Caffeine (0.3 or 0.6 g/L, Sigma-Aldrich,
USA) was added to the drinking water. The Pusan
National University Institutional Animal Care and Use
Committee (PNUIACUC) approved the experimental
procedures.
Examination of brain structure
To examine the brain structure in the rats, magnetic reso-
nance imaging (MRI) (4.7 T Bruker Biospin, Germany or
1.5 T Siemens, Germany) and H&E staining were used. T2-
weighted images in the coronal plane were obtained as
described previously [19]. The cross section areas of the
lateral ventricles and total brain were measured by an
image analysis program (MetaMorph).
Measurement of methylxanthines plasma level
To measure the plasma levels of caffeine and theophyl-
line, a metabolite of caffeine, the rats were sacrificed
around 1:00 PM, 3 days after the MRI. Blood was removed
directly from the heart and was rapidly centrifuged, and
the plasma collected. The procedure used for extraction
and assay of the methylxanthines has been previously
reported [20]. The HPLC analysis was performed as
described by Kaplan et al [21].
Animal preparation and measurement of CSF production
Animal preparation for measurement of CSF production
and cerebral blood flow was performed as previously
described [22]. The rectal temperature was kept at ~37°C.
The arterial O2 tension was maintained at 100-120 mmHg
by adjusting the inspired O2 content, and the arterial CO2
tension was maintained at 33-38 mmHg by adjusting the
tidal volume and respiratory rate. Arterial blood pressure
and pH were monitored as previously described [22]. The
rate of CSF production was measured by the ventricu-
locisternal perfusion method [22]. The animals were
mounted in a stereotaxic frame and a stainless steel can-
nula (27 gauge) was introduced into the lateral ventricle.
Artificial CSF, containing Blue Dextran 2000 (Sigma-
Aldrich, USA), at a concentration of 5 mg/ml, was infused
through the cannula at a rate of 4 μl/ml, while intraven-
tricular pressures were continuously monitored by means
of T connectors inserted into the infusion lines. A stainless
steel cannula (27 gauge) was inserted into the cisterna
magna to enable CSF collection. CSF samples were col-
lected at 10- min intervals and the concentration of Blue
Dextran in the samples was determined colorimetrically
by measuring the absorbance at 620 nm. The rate of CSF
production (Vf) in μl/ml was calculated from the dilution
of Blue Dextran 2000 with the formula Vf = Vi(Ci-Co)/Co
where Vi is the rate of infusion of the perfusate, and Ci and
Co are the concentrations of Blue Dextran in the inflow
and outflow fluids, respectively. For each experiment,
standard curves were prepared using known concentra-
tions of Blue Dextran. To examine the acute effects of ade-
nosine receptor signaling, on CSF production, theBMC Neuroscience 2009, 10:110 http://www.biomedcentral.com/1471-2202/10/110
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following drugs were injected intravenously after a 60-
min ventriculocisternal perfusion. The choice of drugs
and their doses were based on previous reports[3,23,25]:
caffeine (10 mg/kg); [7-(2-phenylethyl)-5-amino-2-(2-
furyl)-pyrazolo-4,3-e]-1,2,4-triazolol[1,5-c]pyrimidine
(SCH58261, A2A receptor antagonist, Sigma-Aldrich, USA,
0.03 mg/kg); 2-p-(2-carboxy-ethyl)phenethylamino-5'-N-
ethylcarboxamido-adenosine (CGS21680, A2A adenosine
receptor agonist, Sigma-Aldrich, USA, 0.5 mg/kg); 8-
cyclopenthyl-1,3-dipropylxanthine (DPCPX, A1 receptor
antagonist, Sigma-Aldrich, USA, 0.1 mg/kg); N6-
cyclopentyladenosine, (CPA, A1 adenosine receptor ago-
nist, Sigma-Aldrich, USA, 0.1 mg/kg). These drugs were
administered intravenously. To measure the respiratory
rate, the up-and-down movement of the abdomen was
counted for 1 min.
Measurement of cerebral blood flow (CBF)
A craniectomy (5 mm in diameter, 2-4 mm lateral and 1-
2 mm caudal to the bregma) was performed with extreme
care over the middle cerebral artery territory. The dura was
kept intact to prevent injury to the cortex. The field was
frequently irrigated with physiological saline. To measure
CBF, a 2.0 mHz pulsed wave Doppler transducer was
attached over the temporal bone windows. In the resting
state, the velocity from the middle cerebral artery was
monitored using TCD equipment (Pioneer TC4040,
Nicolet Vascular Doppler, USA). To measure cerebral per-
fusion, a laser Doppler perfusion imager (Moor Instru-
ment, Devon, UK) was used as described previously [26].
Immunohistochemistry
Immunohistochemistry was performed as previously
described [27]. The animals were anesthetized with
pentobarbital sodium (50 mg/kg) and sacrificed by intrac-
ardiac perfusion with 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4. The brains were post-fixed for 4
h at 4°C with the same fixative and cryoprotected with
30% sucrose. The tissues were frozen using OCT com-
pound embedding medium in dry ice powder. Coronal
sections were cut (30 μm) using a cryostat (LEICA,
CM3050, Germany) and processed for immunohisto-
chemistry. Every sixth section, from the corpus striatum to
the caudal hippocampal region, was immunostained. The
sections were incubated in a blocking buffer (0.3% Triton
X-100 and 10% goat or horse serum in PBS) for 1 h, and
then incubated overnight with primary antibodies in an
incubation buffer (0.1% Triton X-100, 1% goat or horse
serum and 1% bovine serum albumin in PBS) at 4°C. The
sections were then washed three times for 10 min each
with PBS and incubated in HRP-conjugated secondary
antibodies (1:200) for 2 h at room temperature. Then the
DAB reaction was performed. The following primary anti-
bodies were used: anti-Na+, K+-ATPase (1:500, Hybrid-
oma Bank), anti-aquaporin 1 (AQP1) (1:500, Chemicon),
anti-carbonic anhydrase II (CAII) (1:500, Megabase),
anti- A1 adenosine receptor (1:200, Chemicon), and anti-
A2A adenosine receptor (1:200, Millipore) antibodies.
BrdU immunohistochemistry
The rats were injected intraperitoneally with BrdU (50
mg/Kg) every 2 h for 2 days to label the proliferating
choroid epithelial cells. The rats were sacrificed 1 h after
the final injection, and perfused with 4% paraformalde-
hyde in phosphate buffer (pH 7.4). The brain was
removed as a tissue mass and fixed for an additional 6 hrs
in the same fixative and embedded in paraffin. After cut-
ting with a microtome, sections 4 μm thick were deparaffi-
nized and hydrated using xylene and graded methanol.
Deparaffinized and hydrated brain sections were pre-
treated with 50% formamide/280 mM NaCl/30 mM
sodium citrate at 65°C for 2 h, and incubated in 2 M HCl
at 37°C for 1 h. The remaining procedures were the same
as described above for "immunohistochemistry".
Western blot analysis
To remove the choroid plexus and corpus callosum from
the brain tissues, we sliced the brains. Under the stereo-
scope, we dissected them out as purely as possible using a
sharp scalpel. For the Western blotting, the tissues were
homogenized in an ice-cold lysate buffer containing a
cocktail of protease inhibitors (Complete, EDTA-free:
Roche, Germany). After sonication, the samples were cen-
trifuged at 12000 g for 20 min at 4°C, and then the super-
natants were stored at -80°C. Forty μg of tissue lysates
were subjected to 10% sodium dodecyl sulfate-polyacryla-
mide gel electrophoresis (SDS-PAGE). After transfer to
nitrocellulose membranes (Amersham, Little Chalfont,
UK), the membranes were probed with the following pri-
mary antibodies: anti-Na+, K+-ATPase (1:1,000, Hybrid-
oma Bank), anti-aquaporin 1 (1:1,000, Chemicon), anti-
carbonic anhydrase II (1:1,000, Megabase), anti- A1 ade-
nosine receptor (1:1,000, Alpha Diagnostics), and anti-
A2A  adenosine receptor (1:1,000, Millipore) antibody.
After incubating the blots for 1 h at 25°C with secondary
antibodies conjugated with biotin, they were incubated
with the ABC Elite complex (Vectastain ABC Elite Kit, Bur-
lingame, USA) and visualized with the ECL Blotting Anal-
ysis System (Amersham, Little Chalfont, UK).
Data Analysis
The data were presented as the means ± SEM. The differ-
ences between the mean values of two groups were evalu-
ated using the Student's t-test (unpaired comparison). For
comparison of more than three groups, we used a one-
way analysis of variance (ANOVA) followed by Tukey's
multiple comparison analysis. P values < 0.05 were con-
sidered statistically significant.BMC Neuroscience 2009, 10:110 http://www.biomedcentral.com/1471-2202/10/110
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Results
Caffeine (0.3 or 0.6 g/L) was added to the drinking water
for 3 weeks in the present study. This low dose of caffeine
(0.3 g/L) has been shown to be representative of the
standard daily human consumption [28]. Heavy coffee
drinkers might ingest double this dose. While studying
the effects of the long-term consumption of caffeine on
brain function, we noted frequent enlargement of the ven-
tricles in the caffeine-treated rats compared to the control
rats. However, not all caffeine-treated rats developed ven-
triculomegaly. MRI was used to determine the frequency
of ventriculomegaly in the caffeine-treated rats. A cross
section, of the lateral ventricles, was measured using an
image analysis program (MetaMorph, Figure 1). Signifi-
cant enlargement of the lateral ventricles was noted in
40.0% or 41.7% of the caffeine-treated rats at a dose of 0.3
or 0.6 g/L respectively (n = 10 for 0.3 g/L, n = 72 for 0.6 g/
L) (Figure 1). The average cross section area of the lateral
ventricles in the caffeine-treated rats, receiving 0.3 or 0.6
g/L, had an increase of 2.0 to 2.2 fold in the ventricle size
compared to the control rats. However, the difference
between the two groups was not significant. To confirm
the MRI findings, the brains were dissected and stained
with hematoxylin and eosin (H&E). The H&E staining
Long-term consumption of caffeine can induce ventriculomegaly Figure 1
Long-term consumption of caffeine can induce ventriculomegaly. Caffeine (0.6 g/L) was added to the drinking water 
for 3 weeks (n = 72). A. Magnetic resonance images (T2-weighted) of rat brains in the coronal plane are presented anteropos-
teriorly from the striatum to the hippocampus. CSF in the ventricles appears white on the images. B. Measurement of relative 
cross section areas of the lateral ventricles by an image analysis program (MetaMorph). The relative area of the lateral ventri-
cles was calculated as follows: area of lateral ventricles/total brain area*100.
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clearly showed a significant enlargement of the lateral
ventricles (data not shown). Immunochemistry and West-
ern blot analysis were performed on rats that had lateral
ventricles two times larger than the control rats. In addi-
tion, 0.6 g/L of caffeine was added to the drinking water
for long-term consumption experiments.
To determine why only 40% of the caffeine-treated rats
had ventriculomegaly, we measured the plasma levels of
caffeine after performing the MRI. The plasma levels of
caffeine in the rats with ventriculomegaly was 3 times
higher than in rats without ventriculomegaly (0.037 ±
0.008 versus 0.010 ± 0.006 μg/ml, P < 0.05, Table 1). The
range of plasma caffeine concentrations observed in the
rats with ventriculomegaly, was consistent with previous
reports [14].
Ventriculomegaly can be caused by disturbances of CSF
dynamics [29]. If the circulation pathway of the CSF is
blocked, this usually leads to dilatation of the ventricles,
since the production of fluid usually continues despite the
obstruction. Another mechanism is overproduction of
CSF. At first, we focused on the CSF pathway. When we
analyzed MR images and paraffin sections of the brains,
there was no gross physical obstruction in the CSF path-
way identified (data not shown). Next, we measured the
production of CSF using a ventriculo-cisternal perfusion
technique. We found a significant increase in the produc-
tion of CSF in the caffeine-treated rats compared to the
control rats (5.02 ± 0.15 versus 2.95 ± 0.12 μl/min, P <
0.01, Figure 2).
The choroid plexus is the major site of CSF production
[29]. The thin-walled vessels of the choroid plexus allow
for passive diffusion of substances from the blood plasma
into the extracellular space surrounding the choroid epi-
thelial cells. Active transport of CSF is controlled by
numerous transporters that mediate movement across the
choroid epithelium. Na+, K+-ATPase establishes a sodium
gradient across the choroid epithelial cells [30]. Other
proteins including aquaporin I (AQP1) and carbonic
anhydrase II also play an important role in CSF produc-
tion.
To determine the underlying mechanisms involved in CSF
overproduction, in the caffeine-treated rats, we evaluated
the choroid plexus for hyperplasia. No hyperplasia of the
choroid plexus was found by H&E staining or BrdU exper-
iments in the enlarged ventricles of the caffeine-treated
rats (Figure 3). Next we examined the expression of pro-
teins essential for CSF production including Na+, K+-
ATPase, AQP1, and carbonic anhydrase II by immunohis-
tochemistry and Western blotting. We noted a significant
increase in the expression of Na+, K+-ATPase (204.2 ±
11.8% of control, P < 0.01) but not AQP1 or carbonic
anhydrase II (CAII) in the choroid epithelial cells of the
caffeine-treated rats compared to the control rats (Figure
4A-C). Because CBF can also affect the production of CSF
[31], we examined CBF using ultrasound Doppler
(Nicolet Vascular Doppler). We noted a significant
increase in the CBF of the caffeine-treated rats compared
to the control rats (143.3 ± 10.4% of control, P < 0.05, Fig-
ure 4D). The increase of CBF in the caffeine-treated rats
was further supported by an increase in cerebral perfusion
(138.5 ± 9.2% of control, P < 0.05, Figure 4E).
To exclude the possibility that different amounts of water
uptake might have affected the analysis of CSF produc-
tion, we measured the water uptake of one rat in a cage for
3 weeks (n = 10 each group). There was no difference in
the water uptake of this rat compared to the other rats (see
Additional file 1). Moreover, there was no significant dif-
ference in the rate of weight gain between the control rats
and caffeine-treated rats during the experimental period
(see Additional file 2).
Next, we examined the acute effects of caffeine on the pro-
duction of CSF. Unexpectedly, the rats treated with caf-
feine just once, before measurement, showed a
significantly reduced production of CSF, by 22.3% (n =
10, Figure 2C) compared to the control rats; this finding
was contrary to the chronic effects of caffeine on CSF pro-
duction. The acute treatment with caffeine had no signifi-
cant effect on blood pressure and respiratory rate (see
Additional file 3 &4). Because the "effect inversion" of caf-
feine might be caused by up-regulation of a receptor, we
examined the expression of the adenosine receptors A1
and A2A, which have been identified as major targets of
caffeine in the brain after chronic treatment with caffeine.
The immunohistochemistry and Western blotting showed
that the A1, but not the A2A, adenosine receptor, was
increased in the choroid plexus of the caffeine-treated rats
compared to the control rats (569.2 ± 32.3% of control, P
< 0.001, Figure 5A &5B). This suggested that up-regula-
Table 1: Plasma concentrations of caffeine and its metabolite theophylline in caffeine-treated rats.
Caffeine (μg/ml) Theophylline (μg/ml)
Caffeine-treated rats with ventriculomegaly 0.037 ± 0.008 0.68 ± 0.089
Caffeine-treated rats without ventriculomegaly 0.010 ± 0.006 0.34 ± 0.174
Rats were treated with caffeine (0.6 g/L) for 3 weeks and were sacrificed 3 days after MRI imaging. Means ± SEM of 10 rats in each groupBMC Neuroscience 2009, 10:110 http://www.biomedcentral.com/1471-2202/10/110
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tion of the A1 adenosine receptor was involved in the
effect inversion of caffeine. To further confirm the
involvement of the A1 receptor in the chronic effects of
caffeine, we examined whether stimulation of the adeno-
sine receptor was associated with the development of ven-
triculomegaly. Treatment with CPA, an agonist of the
adenoinse A1 receptor, and CGS21680, an agonist of the
adenosine A2A receptor, for 2 weeks caused ventriculome-
galy in 37% of the agonist-treated rats (n = 27, Figure 5D).
Interestingly, expression of Na+, K+-ATPase, but not
AQP1, was increased in the CPA-treated (149.9 ± 7.2% of
control, P < 0.05), but not the CGS21680-treated rats (Fig-
ure 5).
Next, we examined the acute effects of A1 and A2A adeno-
sine receptor agonists and antagonists on CSF production
rate. The acute treatment with an A2A adenosine receptor
agonist or antagonist increased or decreased CSF produc-
tion rate by 21.4% or 16.1% respectively compared to the
control rats (Figure 6). However, the acute effects of the
A1 adenosine receptor agonist and antagonist, on CSF
production, were not significant (Figure 6).
Discussion
Numerous physical effects of caffeine consumption have
been previously described. However, the effects of caffeine
on brain structure and CSF production have not been
reported on, to date. The results of the present study
showed that long-term consumption of caffeine could
cause ventriculomegaly, which appears to be mediated, in
part, by increased production of CSF.
In addition to disturbances in CSF dynamics, reduction in
white matter (periventricular leukomalacia) can cause sec-
ondary ventriculomegaly [32]. Periventricular leukomala-
cia can be caused by hypoxia, perinatal stress and sepsis.
Previous studies have shown that hypoxia-induced ven-
triculomegaly is mediated by the A1 adenosine receptor,
which is a major target molecule of caffeine in the brain
[33,35]. Hypoxia-induced ventriculomegaly was not
observed in mice that were deficient in the A1 adenosine
receptor (A1AR-/-). By contrast, activation of the A1 ade-
nosine receptor, during the first 2 postnatal weeks, leads
to white matter injury. Moreover, ventriculomegaly was
The chronic administration of caffeine increased CSF produc- tion and acute administration decreased it Figure 2
The chronic administration of caffeine increased CSF 
production and acute administration decreased it. A. 
The effect of chronic administration of caffeine on Blue Dex-
tran recovery (Cout/Cin) from the CSF throughout a 60-min 
ventriculocisternal perfusion. The CSF was collected from 
the cisterna magna beginning immediately after the infusion. 
B. The effect of chronic administration of caffeine on the CSF 
production rate. C. The effect of acute administration of caf-
feine on the CSF production rate. Values are expressed as 
means ± SEM from 10 rats in each group. *, P < 0.01; **, P < 
0.05 versus control rats
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also observed in mice lacking the enzyme, adenosine
deaminase, which degrades adenosine [33]. Although we
cannot rule out the possibility of periventricular leukoma-
lacia, caused by long-term consumption of caffeine, the
radiologists did not find any of the signs of leukomalacia
on the brain MRI of the caffeine-treated rats in the present
study.
Different effects of short- and long-term caffeine exposure
have been previously reported [11,17]. The effect inver-
Overproduction of CSF in caffeine-treated rats was associated with induction of Na+, K+-ATPase and increase in cerebral  blood flow (CBF) Figure 4
Overproduction of CSF in caffeine-treated rats was associated with induction of Na+, K+-ATPase and increase 
in cerebral blood flow (CBF). A. Representative photographs of Na+, K+-ATPase, AQP1 and carbonic anhydrase II (CAII) 
immunohistochemistry in the choroid epithelial cells of the control and caffeine-treated rats (n = 4). Scale bar, 100 μm. B. Rep-
resentative Western blots of Na+, K+-ATPase, AQP1 and CAII. C. Analysis of Western blots by image analyzer (LAS 3000, 
Fujifilm, Japan). α-tubulin was used as a control. D. CBF was increased in the caffeine-treated rats. E. Cerebral perfusion was 
increased in the caffeine-treated rats. Values are expressed as the percentage of control (n = 10). *, P < 0.01; **, P < 0.05 ver-
sus control rats
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The effect inversion of caffeine was associated with the induction of the A1 adenosine receptor after long-term caffeine treat- ment Figure 5
The effect inversion of caffeine was associated with the induction of the A1 adenosine receptor after long-term 
caffeine treatment. A. Representative photographs of adenosine A1 and A2A receptor immunohistochemistry in the choroid 
epithelial cells of the control and caffeine-treated rats (n = 4). Scale bar, 100 μm. B. Representative Western blots of the ade-
nosine A1 and A2 receptors. C. Analysis of the Western blots using an image analyzer (LAS 3000, Fujifilm, Japan). α-tubulin was 
used as a control. D. Representative MR images (n = 27) and photographs of Na+, K+-ATPase and AQP1 immunohistochemis-
try of the choroid epithelial cells of the control, CPA-treated and CGS21680-treated rats (n = 4). Scale bar, 100 μm. An A1 
agonist, CPA, and an A2A agonist, CGS21680, were associated with ventriculomegaly. CPA but not CGS21680 was correlated 
with an increased expression of Na+, K+-ATPase but not AQP1. E. Representative Western blots of Na+, K+-ATPase and 
AQP1. F. Analysis of the Western blots using an image analyzer (LAS 3000, Fujifilm, Japan). α-tubulin was used as a control. 
Values are expressed as a percentage of the control (n = 6). The results were analyzed by one-way ANOVA followed by 
Tukey's multiple comparison. *, P < 0.001; **, P < 0.05 versus control rats
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sion of caffeine was also observed in the present study.
The acute treatment with caffeine reduced CSF produc-
tion; however, chronic treatment increased CSF produc-
tion. Three findings from the present study support up-
regulation of the A1 adenosine receptor as associated with
the observed effect inversion of caffeine. First, the expres-
sion of the A1 receptor was up-regulated in the caffeine-
treated rats. Second, A1 agonist treatment was associated
with the development of ventriculomegaly. Third, the
expression of Na+, K+-ATPase was increased in both the
caffeine-treated and the A1 agonist-treated rats. Although
this continues to be debated, many previous reports have
demonstrated up-regulation of the A1 adenosine receptor
in caffeine-treated rats [14,36,39].
However, other mechanisms might also contribute to the
effect inversion of caffeine. Conley et al. showed that the
concentration of adenosine in the blood, after long-term
consumption of caffeine, was increased more than tenfold
[40]. This increase in the blood adenosine, after long-term
consumption, might mediate the effect inversion of caf-
feine. However, the increase in the adenosine levels after
long-term consumption of caffeine has never been repli-
cated [41]. Another possible mechanism is the involve-
ment of the A2A receptor. Because the A2A receptor plays a
critical role in the regulation of the cerebral arteries
[42,43], the increased CBF observed in the caffeine-
treated rats might be mediated by the A2A receptor. More-
over, the A2A receptor agonist, CGS21680, also induced
ventriculomegaly (Figure 5). However, in the present
study, we did not find an increase in the expression of the
A2A receptor in the caffeine-treated rats.
Recently, Yang et al showed that some aspects of the long-
term consumption of caffeine can be replicated by genetic
manipulation of the A1  and A2A  adenosine receptors
[41,44]. Caffeine (0.3 g/l in drinking water for 7-10 days)
and the A1R-A2AR double heterozygote genotype
increased locomotor activity and decreased the heart rate
without significantly influencing body temperature.
Despite the similarities in phenotype, the effects of long-
term consumption of caffeine cannot be explained only
by the blocking of the adenosine receptors. For example
the reduction in heart rate after long-term consumption of
caffeine is not due to the acute block of the adenosine
receptors because acute caffeine administration does not
produce a fall in the heart rate. Moreover, induction of
Na+, K+-ATPase with long-term consumption of caffeine,
in the present study, also cannot be explained by the
blocking of or reduction in the adenosine receptors; this is
because A1 adenosine receptor agonist treatment (Figure
5) and A1 adenosine receptor transgenic mice have been
reported to have increased expression of Na+, K+-ATPase
[45].
Several receptor signaling pathways have been implicated
in the regulation of CSF production. Vasopressin and
angiotensin II have been shown to decrease CSF produc-
tion by epithelial effects and changes in blood supply.
Involvement of the cAMP/PKA pathways and intracellular
calcium, in these receptor signaling pathways, remains
controversial. The results of the present study suggest that
the adenosine receptor(s) may not directly regulate CSF
production. Acute treatment with an A1 agonist or an A1
antagonist did not significantly change CSF production;
these findings suggest that the A1 adenosine receptor may
not regulate CSF production directly (Figure 6). Acute
treatment with the A2A agonist or antagonist increased or
decreased CSF production, respectively (Figure 6). How-
ever, the direct effects of the A2A adenosine receptor on
epithelial cells could not be confirmed, because it regu-
lates cerebral blood flow [42,43]. Therefore, the adenos-
ine receptor appears to regulate CSF production by
controlling the expression of Na+, K+-ATPase and cerebral
blood flow. However, the acute and direct effects of the
adenosine receptor on CSF production require further
study.
Na+, K+-ATPase extrudes 3 Na+ in exchange for 2 K+ during
the hydrolysis of 1 ATP molecule [30]. This enzyme is
located in the luminal surface of the choroid epithelial
cells. By contrast, it is located in the basolateral surface of
all other transporting epithelia, both secretory and
absorptive. The luminal Na+ extrusion, by this enzyme, is
the primary event and driving force of CSF production.
Effects of acute administration of adenosine receptor ago- nists or antagonists on the CSF production rate Figure 6
Effects of acute administration of adenosine receptor 
agonists or antagonists on the CSF production rate. 
Values are expressed as the means ± SEM of 10 rats in each 
group. *, P < 0.05 versus control rats.
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Despite its critical role in CSF production, the regulation
of its activity and expression has been poorly character-
ized. Na+, K+-ATPase is composed of α1, β1, β2 and phos-
pholemman in the choroid plexus. In the present study,
we showed that the A1 adenosine receptor regulates the
expression of Na+, K+-ATPase in the choroid plexus; this
finding is consistent with previous results showing
increased expression of Na+, K+-ATPase in A1 adenosine
receptor transgenic mice [45]. However, it has not been
determined whether adenosine receptor signaling can reg-
ulate the activity of the enzyme directly. On the other
hand, phospholemman has been suggested to be a target
for phosphorylation-activated CSF production [30]
Indeed, phospholemman is activated by PKA and has also
been shown to be involved in the conduction of the anion
current induced by cell swelling. However, PKA-depend-
ent regulation of the Na+, K+-ATPase in the choroid plexus
requires further study.
It is unclear why the blood caffeine levels of rats with ven-
triculomegaly were 3 times higher than in the rats without
ventriculomegaly. There was no difference found in the
daily water uptake and therefore the dose of caffeine was
not significantly different between the controls and caf-
feine treated groups, consistent with a previous report
[14]. Perhaps a difference in the metabolism of caffeine in
the liver might explain these findings. The underlying
mechanism needs to be investigated further.
Conclusion
The results of this study show that the long-term con-
sumption of caffeine can induce ventriculomegaly, which
is mediated in part by increased production of CSF. More-
over, adenosine receptor signaling appears to regulate the
production of CSF by controlling the expression of Na+,
K+-ATPase and CBF.
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